logo

AMIORG vs NOVARTIND: Stock Comparison

AMIORG vs NOVARTIS INDIAUpdated 30 May 25, 4:01 PM ISTNSE & company filings

AMIORG is the larger company by market capitalisation. AMIORG shows a lower P/E, a higher ROE and a higher ROCE, while NOVARTIS INDIA shows faster revenue growth, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMIORG leads 6; NOVARTIND leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMIORGNOVARTIND

Valuation lens

What price are you paying?

Market CapContext only
₹26,674 Cr
₹4,753 Cr
P/E RatioAMIORG has the lower reading
43.06x ✓
48.61x
P/B RatioNOVARTIND has the lower reading
6.82x
5.81x ✓
EPSNOVARTIND has the higher reading
₹8.82
₹13.05 ✓
Book ValueContext only
₹161.24
₹331.23
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
AMIORG is the larger company
₹26,674 Cr vs ₹4,753 Cr
P/E Ratio
AMIORG has a lower P/E
43.06x vs 48.61x
P/B Ratio
NOVARTIND has a lower P/B
5.81x vs 6.82x
EPS
NOVARTIND has higher earnings per share
₹13.05 vs ₹8.82
Revenue Growth (TTM YoY)
NOVARTIND has faster revenue growth
8% vs 0%
EPS Growth (TTM YoY)
AMIORG has faster EPS growth
0% vs -13.8%
Qtr Sales Growth
AMIORG has stronger quarterly sales growth
47.75% vs 14.64%
Qtr Profit Growth
AMIORG has stronger quarterly profit growth
63.27% vs 27.56%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMIORGNOVARTIND
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricAMIORGNOVARTIND
Live Price₹1,176.3₹1,921.6
Day Change-0.31%1.26%
Volume2.43 L12,000
52-Week High₹1,194.2₹2,588.8
52-Week Low₹1,170.1₹950
Distance from 52W High-1.5%-25.77%

Valuation

MetricAMIORGNOVARTIND
Market Cap₹26,674 Cr₹4,753 Cr
P/E Ratio43.06x48.61x
P/B Ratio6.82x5.81x
EPS₹8.82₹13.05
Book Value₹161.24₹331.23
Dividend Yield0%0%

Growth

MetricAMIORGNOVARTIND
Revenue Growth (TTM YoY)0%8%
EPS Growth (TTM YoY)0%-13.8%
Qtr Sales Growth47.75%14.64%
Qtr Profit Growth63.27%27.56%

Profitability & Leverage

MetricAMIORGNOVARTIND
ROE16.97%11.39%
ROCE19.8%14.33%
Net Margin15.93%26.3%
Operating Margin27.62%36.95%
Debt to Equity0.01x0x

Shareholding

As of Sep 2025 • change vs previous quarter
MetricAMIORGNOVARTIND
Promoter Holding0.33%▼ 32.33 pp0%
FII Holding0.17%▼ 16.77 pp0.16%▼ 0.01 pp
DII Holding0.23%▼ 22.15 pp1.36%▲ 0.83 pp
Public Holding0.28%▼ 27.73 pp27.8%▼ 0.81 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMIORG and NOVARTIS INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.